Statistics

Total Visits

Views
Cohort compassionate-use program (CUP) and early access program (EAP) with cabazitaxel (Cbz) plus prednisone (P; Cbz plus P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel (D): Analysis by36

Select a period of time:

Number of views in the range

Views
Cohort compassionate-use program (CUP) and early access program (EAP) with cabazitaxel (Cbz) plus prednisone (P; Cbz plus P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel (D): Analysis by27

Views

Views
March 202510
April 20252
May 20251
June 202510
July 20252
August 20252
September 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore10
Hong Kong9
United States5
Canada1
Spain1
Mexico1
 

Top cities views

Views
Hong Kong9
Los Angeles2
Calgary1
Council Bluffs1
Mexico City1
Minneapolis1